ABSTRACT Background: Caloric restriction is recommended for the treatment of obesity, but it is generally characterized by large interindividual variability in responses. The factors affecting the magnitude of weight loss remain poorly understood. Epigenetic factors (ie, heritable but reversible changes to genomic function that regulate gene expression independently of DNA sequence) may explain some of the interindividual variability seen in weight-loss responses. Objective: The objective was to determine whether epigenetics and gene expression changes may play a role in weight-loss responsiveness. Design: Overweight/obese postmenopausal women were recruited for a standard 6-mo caloric restriction intervention. Abdominal subcutaneous adipose tissue biopsy samples were collected before (n = 14) and after (n = 14) intervention, and the epigenomic and transcriptomic profiles of the high and low responders to dieting, on the basis of changes in percentage body fat, were compared by using microarray analysis. Results: Significant DNA methylation differences at 35 loci were found between the high and low responders before dieting, with 3 regions showing differential methylation after intervention. Some of these regions contained genes known to be involved in weight control and insulin secretion, whereas others were localized in known imprinted genomic regions. Differences in gene expression profiles were observed only after dieting, with 644 genes being differentially expressed between the 2 groups. These included genes likely to be involved in metabolic pathways related to angiogenesis and cerebellar long-term depression. Conclusions: These data show that both DNA methylation and gene expression are responsive to caloric restriction and provide new insights about the molecular pathways involved in body weight loss as well as methylation regulation during adulthood.
INTRODUCTION
In 2005, 1.1 billion adults and 10% of children were overweight or obese worldwide (1) . Obesity is defined as an excessive accumulation of fat resulting from a long-term imbalance between energy intake and expenditure (2) . It has a dramatic effect on an individual's health, with musculoskeletal, pulmonary, and psychosocial-related problems, and is associated with an increased risk of morbidity and mortality attributable to cardiovascular diseases, diabetes, and certain forms of cancer (1, 3) .
Interestingly, only a moderate loss of initial body weight provides significant metabolic improvements (4) (5) (6) . However, weight loss responses to caloric restriction show considerable interindividual variability (7) . Studies of genetically identical monozygotic twins have been particularly useful in disentangling the role of environmental and heritable factors in determining the degree of weight loss. It has been shown that within-pair changes in body fat variability after a caloric deficit is significantly lower than between-pair variability, which suggests that genetic factors have an important influence on an individual's response to caloric deficit (8, 9) . However, the concordance between twin pairs was not complete, which suggests that environmental factors or other DNA sequence-independent mechanisms may be involved.
It has been suggested that monozygotic twin discordance for complex traits such as body weight could be accounted for by epigenetic factors (10, 11) . Epigenetics refers to the heritable, but reversible, regulation of various genomic functions, including gene transcription, that are mediated principally through changes in DNA methylation and chromatin structure (12) . The epigenetic regulation of cellular functions is a normal and essential process in cell development and differentiation, and epigenetic factors are subjected to reprogramming in response to both stochastic and environmental stimuli (12) . Such changes can be mitotically stable and enduring, producing long-term changes to gene expression, but can also be short-lived and rapidly reversed (13) . Indeed, such dynamic epigenetic changes have the potential to offer a mechanism by which cellular metabolism can be rapidly regulated independently of long-term, irreversible evolutionary mutagenesis. Cytosine methylation (C met ), occurring at position 5 of the cytosine pyrimidine ring in CpG dinucleotides, is the best understood epigenetic modification. The methylation of CpG sites disrupts the binding of transcription factors and attracts methyl-binding proteins that are associated with gene silencing and chromatin compaction (14) . Because CpG dinucleotide methylation is associated with the regulation of gene expression, altered DNA methylation could explain interindividual phenotypic differences (15) .
We report here the results of the first comprehensive analysis of epigenomic and transcriptomic responses in subcutaneous adipose tissue after a caloric restriction intervention in overweight and obese women. We found that although both DNA methylation and gene expression differences existed between the high and low responders to dietary restriction after the intervention, only epigenetic differences exist before dieting. These data suggest that the epigenetic profile has the potential to differentiate between good and poor responders to caloric restriction.
SUBJECTS AND METHODS

Study population and experimental design
The sample used in this study was a subsample of a larger weight-loss study (n = 137) aimed at exploring the effect of a caloric restriction intervention on body composition, energy expenditure, insulin sensitivity, and metabolic, inflammatory, hormonal, and psychosocial profiles in overweight and obese postmenopausal women. The recruitment for the larger study began in May 2003. The substudy presented here explored the epigenomic and transcriptomic responses of 14 overweight and obese postmenopausal women to a caloric restriction intervention. All individuals provided written informed consent before their inclusion in the study, which was approved by the Université de Montréal ethics committee.
The inclusion and exclusion criteria of the weight-loss study were presented in detail previously (16, 17) . Briefly, sedentary overweight and obese postmenopausal women were included if they had been weight stable for 3 mo before the study and were not taking medications known to affect cardiovascular function and/or metabolism. The subjects were nonsmokers, had a low-tomoderate alcohol consumption (,2 drinks/d), and were free of diabetes and, uncontrolled thyroid, inflammatory, cardiovascular, or pituitary diseases.
The aim of the medically supervised weight-loss program was to reduce body weight by 10% over 6 mo. To determine the levels of caloric restriction, 500-800 kcal were subtracted from the baseline resting metabolic rate (determined by indirect calorimetry) and then multiplied by a physical activity factor of 1.4, which corresponds to a sedentary state. Dietary prescriptions ranged from 1100 to 1800 kcal/d. The macronutrient composition of the diets was standardized: 55%, 30%, and 15% of energy intake from carbohydrates, fat, and protein, respectively (16) . To reduce the acute effect of weight changes on the outcomes measured, baseline and postintervention measurements as well as adipose tissue biopsy collections were preceded by a 4-wk weight-stability period (within 62 kg), verified on a weekly basis at our research unit. Also, the subjects were instructed not to exercise and to eat a high-carbohydrate diet for the 3 d before the biopsy procedure. Fasting baseline and postintervention subcutaneous adipose tissue biopsy samples were obtained from the periumbilical level at both sides of the body by needle biopsy under local anesthesia (20 mg xylocaine/mL) (18) (19) (20) .
One hundred thirty-seven women were recruited and completed the 6-mo weight-loss program. Baseline and postintervention adipose tissue biopsy samples were available for 29 of these women. Consent for biopsy was an optional part of the larger study. There was no other criteria to be met to be included in the biopsy subsample. Fourteen women were further selected for the current study based on their response to the caloric restriction. Women who lost 3% of their body fat were considered "high responders," whereas those who lost ,3% of their body fat were considered "low responders" to the caloric restriction. Low (n = 7) and high (n = 7) responders were matched for baseline age, BMI, percentage body fat, resting blood pressure, fasting blood lipids, glucose and insulin concentrations, and changes in fat-free mass ( Tables 1 and 2 ).
Anthropometric and metabolic measurements
Standardized procedures were used to measure body weight, height, waist girth, resting blood pressure, and blood lipid, glucose, and insulin concentrations, as previously described (16, 17) . Total energy expenditure was measured by using the doubly labeled water technique (21) , and resting metabolic rate was measured by indirect calorimetry (16, 17) . Total fat mass and fatfree mass were measured by dual-energy X-ray absorptiometry (16, 17) .
DNA and RNA extraction
Genomic DNA was extracted by using the Qiagen DNeasy Blood and Tissue DNA purification kit (Qiagen, Mississauga, Canada). Total RNA was prepared from '50 mg of subcutaneous adipose tissue biopsy samples and was concentrated with the Qiagen RNeasy Lipid Tissue Minikit and Qiagen RNeasy MinElute Cleanup Kit (Qiagen). The concentration (5-10 lg/50 mg fat tissue) and integrity of purified total RNA was verified by using an Agilent 2100 bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Palo Alto, CA).
Microarrays
Epigenomic profiling
Our epigenomic profiling of abdominal subcutaneous adipose tissue used Human CpG-island 15K arrays obtained from the University Health Network (Toronto, Canada). This array contains 14,923 CpG-island clones derived from the Human CpGisland 8.1K array (22) and a set of 6800 additional CpG-island loci. Clones with internal repeat sequences, with multiple or absent BLAST hits, mapped on mitochondrial chromosome or those with .20% overlapping sequences (duplicates) were excluded. Clones from Arabidopsis and the Stratagene's SpotReport Alien cDNA Array Validation System were also spotted on the array and served as controls.
The unmethylated fraction of genomic DNA was enriched for epigenomic profiling, as previously reported (23, 24) . Briefly, 500 ng genomic DNA was digested with the restriction enzyme HpaII (New England Biolabs, Ipswich, MA). The DNA fragments were then ligated with DNA adaptors (annealing products of U-CG1A 5#-CGTGGAGACTGACTACCAGAT-3# and UCG1B 5#-AGTTACATCTGGTAGTCAGTCTCCA-3#) followed by further digestion with McrBC restriction enzyme (New England Biolabs). HpaII cleaves DNA only when the restriction site is unmethylated, whereas McrBC cleaves methylated fragments only. Therefore, both methylation-sensitive restriction enzymes contributed to enrich the unmethylated fraction of genomic DNA. The remaining fragments were then amplified by polymerase chain reaction (PCR) with U-CG1B primer in conditions such that short fragments (,1.5 kb), and thus unmethylated DNA, was preferentially amplified. For each PCR reaction, 80 ng digested genomic DNA were added to a reaction mixture (final volume = 100 lL) containing 6.25 units Taq DNA polymerase (New England Biolabs), 1 · thermopol buffer (New England Biolabs), 2.5 mmol MgCl 2 /L, 125 lmol of each dNTP and 1.5 lmol U-CG1b primer. PCRs were run in triplicate as follow: initial cycle at 72°C for 5 min and 95°C for 1 min, 25 cycles at 95°C for 40 s, 68°C for 2 min, 72°C for 20 s, and a final extension at 72°C for 5 min. The pooled triplicates provided '10 lg enriched DNA for labeling and hybridization. We combined 2.5 lg of each DNA sample to produce a common P 0.00. 5 For the high responders, only 6 samples were available for fasting insulin measurements. 1 DBP, diastolic blood pressure; SBP, systolic blood pressure. None of the differences between groups were statistically significant, P , 0.05 (unpaired t test).
2 For the high responders, only 6 samples were available for fasting insulin measurements.
reference pool that was used to standardize between hybridizations. All samples were labeled with amino-allyl-dUTP, coupled to alexa dyes (alexa 647 for experimental samples and alexa 555 for the reference pool), following the Bioprime Plus Array CGH Genomic labeling system protocol. The labeled probes were then purified and hybridized (via incubation for 16 h at 42°C) on Human CpG-island 15K arrays by using the Advalytix SlideBooster (Advalytix, Munich, Germany) and AdvaHybc hybridization solution. The arrays were scanned on an Agilent G2565BA scanner, quantified with ArrayVision v.8.0 (Imaging Research), and the data were normalized with MIDAS software v.2.19 by using a subgrid intensity-based method. All 28 microarrays passed initial quality control measures and were suitable for analysis.
CpG-island 15K microarray results validation
The Sequenom EpiTYPER (Sequenom Inc, San Diego, CA) approach has been used to determine base-specific cytosine methylation levels of loci showing differential methylation levels using microarray (25) . Briefly, the EpiTYPER assay combines DNA sodium bisulfite conversion chemistry, PCR amplification of target sequences, and base-specific cleavage. The cleavage products are quantitatively analyzed by MALDI-TOF mass spectrometry. The presence of methylated cytosine within the original DNA sequence determines the cleavage pattern. The EpiDESIGNER software has been used for PCR primer selection.
The loci showing the strongest methylation differences in lowand high-methylation groups (DNASE1L2 and TRIM14) were selected for validation as well as the 2 regions with 2 proximal probe sets with methylation differences (chr7p15 and chr10q26). The PCR primers were as follows: DNASE1L2-2f-GTTTAGT-AGTGTTTTGGGAGTTTGT and DNASE1L2-2r-CCTACCC-ACCACACCTATTAATCTA, DNASE1L2-6f-GGGTTTTTTTT-ATTTTTTAGGAAAG and DNASE1L2-6r-ACCACTTAAA-AACCTCACTACTCCTC; TRIM14-4f-TTTTTGGGGTATTTT-TGGTTTTTA and TRIM14-4r-CTTCCCATTTCTAATAAAA-CCACCT, TRIM14-8f-ATGTTTGGGTTGGTTTTTTTAATTT and TRIM14-8r-CCCATCATCAAAACTACAATTTTCT; HOXA6-3f-TGGTTTTTAGAAGTTTTTGTTTTTTTG and HOXA6-3r-CCA-ATCTCCTACCTAAACTAAACCC ; OAT-3f-TGGAATTGGTTT-TATGTATAGGAGG and OAT-3r-AAAACACCAAATAACTCC-CTACCTT, OAT-4f-TGGAATTGGTTTTATGTATAGGAGG and OAT-4r-CAACCAAATTAATAATCAAAACACCA.
Transcriptomic profiling
Affymetrix HG U133 plus 2.0 GeneChip microarrays containing .47,000 transcripts were used to determine the transcriptome of subcutaneous adipose tissue by using the standard manufacturer's protocol (Affymetrix). Briefly, RNA was reverse transcribed into cDNA, and in vitro transcription was performed to generate biotin-labeled cRNA. Biotin-labeled cRNA was then hybridized to microarrays and stained with streptavidin phycoerythrin. Arrays were scanned on a GeneArray scanner. One microarray (high-responder group, postcaloric restriction sample) was discarded because of a low signal intensity likely resulting from poor RNA quality. In total, analyses were performed by using data from 27 microarrays (low-responder group: 7 arrays before and 7 after caloric restriction; highresponder group: 6 arrays before and 7 after caloric restriction).
Expression values were normalized by using the Robust Multiarray Average algorithm (26) , as implemented in FlexArray software (version 1.1) (27) .
Affymetrix HG U133 plus 2.0 GeneChip microarray results validation
Complementary DNA (cDNA) was generated from 40 ng total RNA by using a random primer hexamer following the manufacturer's protocol for Superscript II (Invitrogen, Carlsbad, CA). Primers and TaqMan probes overlapping the first and second exons of each of the selected genes were obtained from Applied Biosystems ( Table 3) . Each sample was analyzed in duplicate and calibrated to LRP10 and GAPDH genes (endogenous control; LRP10: Hs00204094_m1; GAPDH: Hs99999905_m1). Relative quantification estimations were performed on an Applied Biosystems 7500 Real Time PCR System as recommended by the manufacturer (Applied Biosystems, Foster City, CA), and the DDC T calculation method was used to evaluate the mean fold expression differences (MFED) between the 2 groups (28).
Statistics
Sample characteristics
Baseline anthropometric and metabolic characteristics and changes in these characteristics in the low and high responders to caloric restriction were tested by using an unpaired t test. Correlations were tested by using Spearman rank correlation coefficients; t tests and correlations were performed by using SAS software, version 9.1.3 (SAS Institute, Cary, NC).
Microarray-data analysis
Significance Analysis of Microarray (SAM) (29) was used to determine significant differences in DNA methylation (via CpGisland arrays) and expression levels (via expression arrays) between the low-and high-responder groups before and after dieting. A modified t test was applied to each probe set (log 2 transformed), and the raw P values were converted to the false discovery rate (FDR, q values) to correct for multiple testing according to Benjamini and Hochberg (30) . The same procedure was applied to analyze the CpG-island validation results. For gene expression arrays, the significance threshold was set to detect at least a 1.20-fold change, with an FDR value 0.05. Because the number of differentially methylated genes identified was limited on the basis of the same criterion used for the methylation experiment, a minimum fold-change of 1.15-fold and an FDR ,0.10 were used instead to establish significant differences between the groups. In Table 3 , Table 4 , and Table  5 and in supplementary Tables 1 and 2 (see "Supplemental data" in the online issue), the low-responder group was the reference for fold-change computation.
Power estimates for CpG-island and expression microarray experiments
We assessed the power of the present study sample in SAM using a test based on the permutation analysis of real data (31) . This analysis estimates the SD of each gene and the overall null distribution of the genes. The results provide accurate estimates of the power (1-FDR) according to the number of samples. This approach has the advantage that it is based on a real data set and takes into account gene correlation. The mean difference in DNA methylation or mRNA levels used for power computation was 1.4-fold, which we consider to be a reasonable estimate based on the observed mean differences from the list of significant genes obtained from SAM.
As estimated by the method proposed by Tibshirani (31), the power to detect differences in DNA methylation level was .90% before caloric restriction and .99% after caloric restriction (14 arrays each). For the expression arrays, the power to identify genes with mean expression changes of 1.4-fold was .60% before dieting (13 arrays) and .80% after dieting (14 arrays). 1 Genes in the vicinity of those identified in the table [gene symbol, gene symbol (5#), and gene symbol (3#) columns] may also have been affected by the identified DNA methylation changes. HWL, high-weight-loss group. A modified t test was applied as implemented in Significance Analysis of Microarray to each probe set (log 2 transformed), and the raw P values were converted to the false discovery rate (q values) to correct for multiple testing according to Benjamini and Hochberg (30) . 2 The low responders were the reference group for fold-change computation. The change reflects the mean methylation levels computed before and after weight-loss treatment separately for each locus.
Pathway analysis
Pathway analyses allowed us to determine whether genes found to be differentially expressed belong to predefined networks more than expected by chance alone and help to add structure to the vast amount of data generated by microarrays. The Database for Annotation, Visualization, and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/home.jsp), a web-based program (32), allowed us to classify our differentially expressed genes into shared biological categories or chromosomal localization. DAVID computes Fisher's exact P values and their resulting FDR (q value).
RESULTS
Effects of caloric restriction
At baseline, the anthropometric and metabolic characteristics were not significantly different between the low and high responders to caloric restriction (Table 1) . By design, the high responders had stronger overall changes in adiposity than did the low responders (Table 2 ). On average, the 2 groups lost 1.81 61.84 and 7.34 63.05 kg (P , 0.01) of fat mass, respectively, whereas changes in fat-free mass were not significantly different between groups. Accordingly, changes in percentage body fat showed very comparable trends, as compared with changes in fat mass. In accordance with differences in fat mass loss between the groups, leptin gene expression was down-regulated by 1.24-fold (FDR = 0.0875) in the high-fat-loss group compared with the nonresponsive women. No correlation between initial anthropometric and metabolic characteristics and changes in body composition was observed (percentage body fat; Spearman correlation coefficient = 0.30, P = 0.30).
As presented in Table 2 , body fat loss in response to caloric restriction was very heterogeneous among the participants, ranging from a gain of 0.77 kg to a loss of 12.98 kg. There was no significant difference between the 2 groups in the changes in blood pressure, lipid profile, and glucose and insulin values after the intervention.
Epigenomic profiling (CpG-island profiling)
Adipose tissue epigenomic profiling before dieting Before caloric restriction, 35 loci were differentially methylated (FDR , 0.10) between the groups ( Figure 1 and Table 3 ). Three loci were relatively hypomethylated in the high-responder group compared with the low-responder group, whereas 32 loci were relatively hypermethylated in the high-responder group. For 2 regions (chromosomes 7p15 and 10q26), supportive evidence for differential methylation was provided by 2 adjacent probe sets located within a range of ,3 Mb. Interestingly, these 2 regions, in addition to a region nominated on chromosome 1p36, were previously identified as human imprinted loci (33) .
The most biologically relevant genes identified were the potassium channel, voltage-gated, shaker-related subfamily, member 3 (KCNA3; 1.24-fold), the glis family zinc finger protein 3 (GLIS3; 1.24-fold), the V-ets avian erythroblastosis virus E26 oncogene homolog 1 (ETS; 1.18-fold), the nuclear factor I/X (NFIX; 1.16-fold), and insulinoma-associated 1 (INSM1; 1.21-fold; directly flanking the C20orf74). Other genes located in the vicinity ('0.5 Mb apart) of the differentially methylated loci were also of early interest. Of these, corticotropin-releasing hormone receptor 2 (CHRH2; 1.15-fold) was located at 0.6 Mb of the PLEKHA8 gene (chromosome 7p15); enoyl-CoA hydratase, short-chain, 1, mitochondrial (ECHS1; 1.18-fold) was found at 0.05 Mb of the SPRN gene (chromosome 10q26); and cholecystokinin B receptor (CCKBR; 1.17-fold) was located at 0.2 Mb of the HPX gene (chromosome 11p15).
Epigenomic profile adaptation to caloric restriction
Probes near 3 loci (chromosomes 1p36, 4q21, and 5q13) were found to be differentially methylated after caloric restriction (Table 3 ). For each of these loci, postintervention DNA methylation levels were higher in the high-responder group than in the low-responder group. Given the postulated role of ectodermalneural cortex 1 gene (ENC1) in obesity (34) and our observation that it was also differentially expressed in the present study (see below), the most attractive locus found to be differentially methylated after caloric restriction was located at 5q13 (1.38-fold)-the genomic region to which ENC1 belongs. ENC1 was found at '1 Mb from the probe set UHNhscpg0025297 on chromosome 5q13 (Table 3) .
The probe set UHNhscpg0018526, located on chromosome 4q21 (located in the vicinity of PRDM8), was the only one to demonstrate differential methylation both before and after intervention.
CpG-island microarray results validation
We further investigated DNA methylation across several loci nominated from our epigenomic microarray analyses. A total of 4 CpG dinucleotides within 2 loci showed significant methylation differences by using the bisulfite-based Sequenom EpiTYPER analysis approach. Three of these CpG were located in the DNASE1L2 probe set (CpG 15, 16, and 17; P = 0.002; FDR = 0%). DNA methylation across all 3 CpG sites was highly correlated with one other and positively correlated with the CpG-island array results (Spearman r = 0.71, P = 0.005). Another CpG dinucleotide with significant methylation differences between the groups was located within the OAT probe set (CpG 21: P = 0.002 and FDR = 0%). The results correlated significantly with the microarray results (Spearman r = 20.74, P = 0.003) ( Table  4 ). The regions tested with bisulfite sequencing are somewhat arbitrary, and it is likely that the specific critical CpG sites causing differential enrichment (and thus microarray signal intensity) were not included in all the amplicons tested. However, the observation that differential methylation was confirmed within the sequence of 2 out of 4 probe sets tested suggests that the microarray data reflect true differences. See Supplementary Figure 1 (under "Supplemental data" in the online issue) for Spearman correlation coefficients between CpG-island results and corresponding HpaII-validated restriction sites.
Gene expression profiling
Adipose tissue transcriptome before and after dieting
None of the tested genes showed differential adipose tissue gene expression between the groups before caloric restriction. However, after caloric restriction, a total of 334 transcripts were up-regulated (1.2-fold to 2.39-fold), whereas 342 transcripts were down-regulated (21.2-fold to 24.25-fold) in the high-responder group as compared with the low-responder group (see supplementary Tables 1 and 2 under "Supplemental data" in the online issue). The differentially expressed genes with 1.5-fold expression differences are shown in Table 5 . These transcripts correspond to 327 and 317 differentially expressed genes in each group, respectively. The gene encoding cholesteryl ester transfer protein (CETP; NM_000078; chromosome 16q21) demonstrated the highest increase in mRNA levels (2.40-fold), and, among down-regulated genes, that encoding phosphoserine phosphatase (PSPH; NM_004577; chromosome 7p15) was the most responsive (24.25-fold). Only 5 other genes showed MFEDs .2, and these were all found to be up-regulated: PHLDA2 (chromosome 11p15.5), SFRP4 (chromosome 7p14.1), and 3 other hypothetical genes. Other genes of interest based on biological function were those encoding phospholipase A2 group 6 (PLA2G6, 1.29-fold), phospholipase C beta 1 and beta 2 (PLCB1, 1.35-fold; PLCB2, 1.29-fold), retinoic acid receptor gamma (RARg, 1.27-fold), SH2Badaptor protein 2 (SH2B2, 1.39-fold), nitric oxide synthase 1 (NOS1, 1.23-fold), sex hormone-binding globulin (SHBG, 1.29-fold), angiopoietin 2 (ANGPT2, 21.41-fold), tumor necrosis factor receptor-associated factor 3 (TRAF3, 21.27-fold), oxysterol binding protein-like 11 (OSBPL11, 21.55-fold), glucocorticoid receptor DNA binding factor 1 (GRLF1, 21.32-fold), and protein inhibitor of activated STAT, 2 (PIAS2, 21.35-fold).
Interestingly, 5 differentially expressed loci were also found to be differentially methylated. These loci were located on chromosomes 3q21 (KPNA1), 5q13 (ENC1), 6q27 (C6orf120), 11p15 (HPX), and 15q15 (HYPK). For these loci, DNA methylation and gene expression were correlated for most of the probe sets ( Table 6 ).
Expression microarray results validation
A total of 11 genes showing 1.5-fold mRNA level differences were validated by real-time PCR ( Table 7) . Seven of these 1 NA, not available; ID, identification. A modified t test was applied as implemented in Significance Analysis of Microarray to each probe set (log 2 transformed), and the raw P values were converted to the false discovery rate (q values) to correct for multiple testing according to Benjamini and Hochberg (30) . The low responders were the reference group for fold-change computation. genes showed comparable MFEDs, with a strong correlation between microarray and real-time PCR results. TXN also showed very similar MFEDs with both methods, but the correlation between microarray and real-time PCR results was modest. Overall, most of the genes tested were validated by RT-PCR, which suggests that our microarray data represent true expression changes.
Pathway analysis
DAVID software (32) was used to identify Gene Ontology [GO, biological processes (BP)] terms, KEGG metabolic pathways, and chromosomal localizations in which a significant proportion of differentially expressed genes could be found. We report here only the most significant findings (P 0.05 and FDR 0.20). For up-regulated transcripts, none of the GO-BP terms reached this significance level. However, the cerebellar longterm depression pathway was identified as the most significant KEGG term (P = 0.02, FDR = 0.19). The differentially expressed genes falling into this category were as follows: PLCB1, PLCB2, PLA2GVI, GNAO1, NOS1, and GUCY1B2. For the down-regulated genes, protein transport, blood vessel development, and vasculature development GO-BP terms were identified (P = 0.002, FDR = 0.04; P = 0.006, FDR = 0.10; and P = 0.006, FDR = 0.10, respectively), but these genes did not belong to any of the tested KEGG metabolic pathways. The differentially expressed genes falling into the protein transport category were as follows: TMEM48, EXOC2, RAB9A, C18orf55, SRP19, PEX13, CHMP2B, TIMM17A, TLOC1, KPNA1, SCFD2, RAB2A, SDAD1, PTPN11, NVTF2, RAB1A, RAB3IP, VPS37A, and PAMC1. Those expressed in blood vessel development and vasculature development were as follows: PDGFA, LAMA4, ANGPT1, ANGPT2, C9orf105, and CHD7. Finally, up-regulated genes were more likely to be located on chromosomes 3q21 (P = 0.007, FDR = 0.12) and 22q11.23 (P = 0.01, FDR = 0.17). These genes were as follows: ABTB1, IFT122, and MYLK for the 3q21 region and C22orf15, DERL3, GGH, HS.648268, and 203877_AT for the latter region.
DISCUSSION
The aim of this study was to document genome-wide dynamic adaptations to caloric restriction in terms of cytosine methylation and transcriptional activity occurring in adipose tissue. Our hypothesis was that failure to respond satisfactorily to caloric restriction in terms of fat mass loss could be accounted for by epigenomic and/or transcriptomic differences. At baseline, we found that despite various loci being differentially methylated between low and high responders to caloric restriction, none of However, the observation of adipose tissue DNA methylation differences characterizing each group at baseline suggests that the epigenomic profile could represent a more promising approach to differentiate low from high responders to caloric restriction. Of the gene loci showing differential DNA methylation, 2 general categories emerged. KCNA3 and NFIX are representative of the first category and are associated with weight control. Knockout (KO) mice for both genes weigh significantly less than wild-type animals and are resistant to weight gain (36, 37) . INSM1, GLIS3, and CCKBR are representative of the second category and are associated with diabetes and/or insulin secretion. INSM1-KO mice have impaired pancreatic b cell development and therefore insulin production and secretion (38) . Defects in GLIS3 production are thought to be responsible for permanent neonatal diabetes and congenital hypothyroidism in human patients (39) . Cholecystokinin (CCK) is a brain and gut satiety peptide secreted in response to a meal that has the capacity to stimulate insulin secretion through the activation of its receptors, CCKAR and CCKBR (40) . Finally, the differentially methylated region on chromosome 11p15 is located only 4.5 Mb from the IGF2-H19 imprinted gene cluster, known to be associated with growth regulation (41, 42) . The insulin-like growth factor 2 gene (IGF2) is normally paternally expressed and has been associated with eating disorders. Interestingly, a recent study showed altered DNA methylation across IGF2 in individuals exposed to prenatal famine and low calorific intake (43) . Overall, even if only a small number of gene loci were found differentially methylated, this approach identified several strong candidate genes and proved to be potentially useful to differentiate low from high dietary responders.
After caloric restriction, only 3 chromosomal regions were differentially methylated between the groups. This strongly suggests that epigenetic markers are responsive to dieting. However, there is no obvious explanation for the modest number of genes that were differentially methylated, but it is possible that qualitative improvements in the diet, independently of fat mass loss, may have made both groups more comparable in terms of methylation patterns. In contrast, adipose tissue gene expression profiles appear to be strongly responsive to caloric restriction with a total of 644 genes showing differential transcript levels after the intervention, compared with none at baseline. The cholesterol ester transfer protein (CETP; chromosome 16q21) is 1 of the top 3 genes based on MFEDs between the groups and is of biological relevance to obesity. CETP is well known for its role in mediating the transfer of cholesterol ester (CE) and triglycerides among plasma lipoproteins (44) (45) (46) but has recently been shown to be associated with lipid metabolism and storage in adipose tissue (47) . The results of a recent study suggest that higher CETP concentrations in adipocytes facilitate lipid transport to cellular sites, where access to hydrolytic enzymes is improved and therefore their utilization in situation of caloric restriction may be made easier (48) . Thus, in our study, the greater body fat loss in the high-responders group may be attributed, at least in part, to the increased adipose tissue CETP expression. At the molecular level, no evidence of differential DNA methylation was found for both probes located in the vicinity of the CETP gene. Some polymorphisms have been shown to affect CETP plasma concentrations (49, 50) and weight loss (51), but our study was not designed to test this specific hypothesis. Further studies are therefore needed to explore the potential dysregulation of CETP cis and trans regulatory elements in weight loss.
Whereas the transcriptome is probably of limited use in differentiating dietary responders before an intervention, gene expression profiling after weight loss is more likely to be useful in identifying genes and metabolic pathways that have to be activated or repressed to achieve a better fat mass loss. Our pathway analysis results suggest that down regulation of genes involved in angiogenesis characterizes high responders to caloric restriction. Given that angiogenesis dysregulation has been associated with obesity and its metabolic complications (52) , achieving downregulation of these genes in the adipose tissue of obese individuals could offer a better prognosis in terms of fat mass loss (53) . On the other hand, the analyses showed that some of the upregulated genes in the high-responders group were associated with cerebellar long-term depression pathway. In the cerebellum, this pathway is associated with memory and learning, and its long-term depression has been associated with expression changes for many genes (54) . The brain-derived neurotrophic factor (BDNF) is one of these genes and has been associated with obesity and weight control in numerous studies (55) . However, it was not found to be differentially expressed in this study, and the role of this pathway in human adipose tissue remains to be determined. Finally, more up-regulated genes than would be expected by chance alone were localized on chromosomes 3q21 and 22q11, which suggests that long-range DNA modifications may have impaired gene expression at these loci. Interestingly, differential methylation levels were also found for probes in the chromosome 3q21 region. However, it is not possible to determine whether the chromosome 3q21 locus signal corresponds to a larger genomic region than the one identified by the probe set contained on the microarrays used in this study.
In this study, DNA methylation and gene expression were correlated for a limited number of genes. Our data thus concur with findings from the pilot Human Epigenome Project, which suggest that the relation between the promoter methylation and transcription is not necessarily straightforward. Whereas there was a clear correlation between DNA methylation and gene expression for some loci, this was not the case for most of the genes (56) . DNA methylation has several other genomic functions in addition to regulating gene expression, including protecting the genome against retroviral elements and playing a key role in DNA replication, which should be taken into account when interpreting the results.
A limitation of our study was that only a fraction of the genome could be interrogated using restriction enzymes. Indeed, DNA methylation at CpG dinucleotides can be assessed only if they are located within McrBC [PuC met (N 40-3000 )PuC met ] or HpaII (unmethylated CCGG) restriction sites. Therefore, it is plausible that the remaining fraction of the genome harbors additional regions showing differential methylation levels. Nevertheless, this approach has proven to be effective (23) and more sensitive than other strategies used to identify small DNA methylation differences (57) , such as those expected (44, 58) . Moreover, it has been shown that the methylation levels of neighboring cytosines correlate with one another, expanding the theoretical genome coverage of this approach. Finally, although the current sample size provided acceptable statistical power, the number of samples used was still limited. Accordingly, these results need to be validated in a larger study.
In summary, our results showed significant epigenomic and transcriptomic differences in adipose tissue between the high and low responders to caloric restriction. Furthermore, our data showed that the epigenetic and transcriptomic profiles differentiating these groups were responsive to the intervention. Whereas the results suggest that DNA methylation profiling could be used to predict good responders to dieting, gene expression profiling may enable the identification of genes and metabolic pathways that have the potential to improve fat mass loss. Understanding adipose tissue molecular adaptation to caloric restriction may provide an opportunity to understand the mechanisms put in place to protect the body's energy reserves and may thus help to tailor obesity prevention and treatment interventions.
